Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based study

European Journal of Cancer

Volumn 43, Issue 3, 2007, Pages 472-475

  Eder, Tanja ^a   Mayer, Ramona ^a   Langsenlehner, Uwe ^a   Renner, Wilfried ^a   Krippl, Peter ^a   Wascher, Thomas C ^a   Pummer, Karl ^a   Kapp, Karin S ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Genetic epidemiology; Haplotype; Interleukin 10; Prostate cancer; Single nucleotide polymorphisms

Indexed keywords

INTERLEUKIN 10; NUCLEASE;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33846581376     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.11.003     Document Type: Article

References (21)

1. Parkin D.M., Whelan S.L., Ferlay J., Raymond L., and Young J. Cancer incidence in five continents VII (1997), IARC Scientific Publications, 143, International Agency for Research in Cancer, Lyon
2. Nomura A.M., and Kolonel L.N. Prostate cancer: a current perspective. Epidemiol Rev 13 (1991) 200-227
3. Kolonel L.N., Nomura A.M., and Cooney R.V. Dietary fat and prostate cancer: current status. J Natl Cancer Inst 91 (1999) 414-428
4. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
5. Singh R, Eeles RA, Durocher F et al., The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Labrie F, Easton D, Narod SA, Tonin PA, Foulkes WD, editors. High risk genes predisposing to prostate cancer development- do they exist? Prostate Cancer and Prostatic Diseases 2000;3:241-7.
6. Mocellin S., Marincola F., Rossi C.R., Nitti D., and Lise M. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 15 (2004) 61-76
7. Mocellin S., Marincola F.M., and Young H.A. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 78 (2005) 1043-1051
8. Filella X., Alcover J., Zarco M.A., Beardo P., Molina R., and Ballesta A.M. Analysis of type T1 and T2 cytokines in patients with prostate cancer. Prostate 44 (2000) 271-274
9. Mocellin S., Panelli M.C., Wang E., Nagorsen D., and Marincola F.M. The dual role of IL-10. Trends Immunol 24 (2003) 36-43
10. Sharma N., Luo J., Kirschmann D.A., et al. A novel immunological model for the study of prostate cancer. Cancer Res 59 (1999) 2271-2276
11. Stearns M.E., Wang M., Hu Y., Garcia F.U., and Rhim J. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. Clin Cancer Res 9 (2003) 1191-1199
12. Lim S., Crawley E., Woo P., and Barnes P.J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352 (1998) 113
13. Edwards-Smith C.J., Jonsson J.R., Purdie D.M., Bansal A., Shorthouse C., and Powell E.E. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30 (1999) 526-530
14. Lowe P.R., Galley H.F., Abdel-Fattah A., and Webster N.R. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 31 (2003) 34-38
15. Hutchinson I.V., Pravica V., Hajeer A., and Sinnott P.J. Identification of high and low responders to allografts. Rev Immunogenet 1 (1999) 323-333
16. Langsenlehner U., Krippl P., Renner W., et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 90 (2005) 113-115
17. Xu J., Lowey J., Wiklund F., et al. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 2563-2568
18. Michaud D.S., Daugherty S.E., Berndt S.I., et al. Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 66 (2006) 4525-4530
19. McCarron S.L., Edwards S., Evans P.R., et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62 (2002) 3369-3372
20. Ioannidis J.P., Gwinn M., Little J., et al. Human Genome Epidemiology Network and the Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology. Nat Genet 38 (2006) 3-5
21. Hirschhorn J.N., Lohmueller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61